G6PD and malaria: Another concern of Vc-mediated Plasmodium inhibition is individuals with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, an observed genetic trait in malaria-endemic regions (Cappellini and Fiorelli, 2008).